A study of topical CGS-125 for treatment of subjects with osteoarthritic knee pain

Trial Profile

A study of topical CGS-125 for treatment of subjects with osteoarthritic knee pain

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 27 Nov 2015 New trial record
    • 23 Nov 2015 Results published in a CapGenesis Therapeutics media release.
    • 23 Nov 2015 This study was conducted at a single site in the Dominican Republic under the supervision of an Institutional Review Board (IRB) and the National Council on Bioethics in Health (CONABIOS), which functions as a Dominican national IRB.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top